期刊文献+

Identification of Hypertension Subgroups through Topological Analysis of Symptom-Based Patient Similarity 被引量:1

原文传递
导出
摘要 Objective:To obtain the subtypes of the clinical hypertension population based on symptoms and to explore the relationship between hypertension and comorbidities.Methods:The data set was collected from the Chinese medicine(CM)electronic medical records of 33,458 hypertension inpatients in the Affiliated Hospital of Shandong University of Traditional Chinese Medicine between July 2014 and May 2017.Then,a hypertension disease comorbidity network(HDCN)was built to investigate the complicated associations between hypertension and their comorbidities.Moreover,a hypertension patient similarity network(HPSN)was constructed with patients'shared symptoms,and 7 main hypertension patient subgroups were identified from HPSN with a community detection method to exhibit the characteristics of clinical phenotypes and molecular mechanisms.In addition,the significant symptoms,diseases,CM syndromes and pathways of each main patient subgroup were obtained by enrichment analysis.Results:The significant symptoms and diseases of these patient subgroups were associated with different damaged target organs of hypertension.Additionally,the specific phenotypic features(symptoms,diseases,and CM syndromes)were consistent with specific molecular features(pathways)in the same patient subgroup.Conclusion:The utility and comprehensiveness of disease classification based on community detection of patient networks using shared CM symptom phenotypes showed the importance of hypertension patient subgroups.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2021年第9期656-665,共10页 中国结合医学杂志(英文版)
基金 Supported by the National Key Research and Development Project of China (No. 2017YFC1703502 and No. 2017YFC1703506)。
  • 相关文献

参考文献4

二级参考文献19

  • 1李旭.浅谈《伤寒论》辨证思维方式[J].河南中医,2004,24(10):1-2. 被引量:2
  • 2刘渡舟.方证相对论[J].北京中医药大学学报,1996,19(1):3-5. 被引量:113
  • 3《中国高血压防治指南》修订委员会.高血压的危险分层.《中国高血压防治指南》修订委员会.中国高血压防治指南2005年修订版.北京:人民卫生出版社,2006.15.
  • 4Chen W,Chen W,Wang H,et al.Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China.Nephrol Dial Transplant,2009,24:1205-1212.
  • 5Chen N,Wang W,Huang Y,et al.Community-based study on CKD subjects and the associated risk factors.Nephrol Dial Transplant,2009,24:2117-2123.
  • 6Chen W,Wang H,Dong XQ,et al.Prevalence and factors associated with CKD:a population study from Guangzhou.Chin J Nephrol,2007,23:147-151.
  • 7Zhang L,Zhang P,Wang F,et al.Prevalence and factors associated with CKD:a population study from Beijing.Am J Kidney Dis,2008,51:373-384.
  • 8Mancia G,De Backer G,Dominiczak A,et al.2007 Guidelines for the Management of Arterial Hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).J Hypertens,2007,25:1105-1187.
  • 9Gerstein HC,Mann JF,Yi Q,et al.Albuminuria and risk of cardiovascular events,death,and heart failure in diabetic and nondiabetic individuals.JAMA,2001,286:421-426.
  • 10Jensen JS,Feldt-Rasmussen B,Strandgaard S,et al.Arterial hypertension,microalbuminuria,and risk of ischemic heart disease,2000,35:898-903.

共引文献43

同被引文献27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部